Document is current
Any future updates will be listed below
-
Authors
Levine, Jasmine
Islam, Rahib K
Mo, Lillian
Maltese, Alexander
Adalsteinsson, Jonas
Talia, Jordan
Gulati, Nicholas
Ungar, Benjamin
- License Information
-
More Information
Article History
Received: 12 March 2025
Revised: 12 March 2025
Accepted: 25 April 2025
First Online: 14 May 2025
Declarations
:
: JT has served as consultant for Abbvie, Arcutis Biotherapeutics, Bristol Myers Squibb, Calliditas Therapeutics, J&J, LEO Pharma, Primus Pharmaceuticals, Sanofi Genzyme, Stifel Financial and UCB. NG is an employee of Mount Sinai and has served as a consultant for Almirall, Daiichi Sankyo, and Primus Pharmaceuticals. BU is an employee of Mount Sinai and has received research funds (grants paid to the institution) from: Bristol Myers Squibb, Incyte, Rapt Therapeutics, Pfizer, and Sanofi. He is also a consultant for AbbVie, Arcutis Biotherapeutics, Bristol Myers Squibb, Botanix Pharmaceuticals, Castle Biosciences, Fresenius Kabi, Galderma, J&J, Leo Pharma, Lilly, Pfizer, Primus Pharmaceuticals, Sanofi, and UCB.
: Not applicable.
: This study was exempt from Mount Sinai Institutional Review Board oversight because it exclusively used de-identified data from patients.
